Image

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

Recruiting
18-85 years
All
Phase N/A

Powered by AI

Overview

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer.

The main question it aims to answer are:

  • Which diagnostic modality is preferred by patients and the general population?
  • Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality?
  • Are geographical differences present in regard to the preference for a diagnostic modality?

Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.

Eligibility

Inclusion Criteria:

  1. Individuals >18yo to 75yo (upper age limit of Barrett's surveillance)
  2. Access to computer or smartphone
  3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)

Exclusion Criteria:

  1. Individuals less than 18yo and more than 75yo
  2. Incarcerated individuals

Study details
    Esophageal Cancer
    Gastric Cancer

NCT06346080

KU Leuven

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.